skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Pharmacological modulation of brain levels of glutamate and GABA in rats exposed to total sleep deprivation

Original Research

(2106) Views  (719) Full article downloads

Authors: Sahar Mohamed Kamal

Published Date June 2010 Volume 2010:2 Pages 65 - 71
DOI: http://dx.doi.org/10.2147/JEP.S11143

Sahar Mohamed Kamal

Pharmacology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Abstract: Modulation of gamma-aminobutyric acid (GABA) and glutamate by selected antidepressants and anticonvulsants could play a beneficial role in total sleep deprivation (TSD) caused by depressed mood. In the present study, albino rats were exposed to TSD for five days. On the sixth day, the brains were removed, and GABA and glutamate levels were measured in the prefrontal cortex and thalamus to identify TSD-induced changes in untreated rats and in rats treated with carbamazepine 40 mg/kg intraperitoneally (IP), fluoxetine 20 mg/kg IP, or desipramine 10 mg/kg IP. Carbamazepine and fluoxetine significantly increased GABA and reduced glutamate levels in both brain areas. Desipramine administration did not affect GABA or glutamate concentrations in the tested brain areas; levels were comparable with those induced by TSD without treatment. These results suggest that administration of carbamazepine or fluoxetine could have a beneficial effect by increasing GABA levels during TSD.

Keywords: total sleep deprivation, antidepressants, carbamazepine, GABA, glutamate, rats






 

Other articles by Dr Sahar Kamal



Readers of this article also read:

Duloxetine for the management of fibromyalgia syndrome
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
Effects of an oral dose of l-glutamic acid on circulating neurotransmitters: Possible roles of the C1(Ad) and the A5(NA) pontomedullary nuclei
Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats
Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence
Preferences related to attention-deficit/hyperactivity disorder and its treatment
Role of calcium in morphine dependence and naloxone-precipitated withdrawal in mice
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
Effects of single-dose morning and evening administration of pravastatin on antioxidant markers in cholesterol-fed rabbits
Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University